News & Research Highlights
News
News
Scientists identify 95 regions of genome linked to PTSD (https://www.nature.com/articles/s41588-024-01707-9)
Scientists identify 95 regions of genome linked to PTSD (https://www.nature.com/articles/s41588-024-01707-9)
Scientists identify 43 genes associated with PTSD (https://www.broadinstitute.org/news/scientists-uncover-95-regions-genome-linked-ptsd).
Scientists identify 43 genes associated with PTSD (https://www.broadinstitute.org/news/scientists-uncover-95-regions-genome-linked-ptsd).
CHCF is now member of ABC, American Brain Coalition (https://www.americanbraincoalition.org/).
CHCF is now member of ABC, American Brain Coalition (https://www.americanbraincoalition.org/).
CHCF is now part of the biggest advocacy group, Alliance for Regenerative Medicine (ARM) that promotes the discovery of novel therapeutics for diseases of brain. This will allow CHCF to promote research with focus on mental health more effectively (https://www.linkedin.com/feed/update/urn:li:activity:7131870766249189376).
CHCF is now part of the biggest advocacy group, Alliance for Regenerative Medicine (ARM) that promotes the discovery of novel therapeutics for diseases of brain. This will allow CHCF to promote research with focus on mental health more effectively (https://www.linkedin.com/feed/update/urn:li:activity:7131870766249189376).
The Workshop proceeding white paper covering the development and qualification of biomarkers for Central Nervous System including but not limited to neuron-psychiatry is out as a chapter (https://lnkd.in/dBghcGEP8).
The Workshop proceeding white paper covering the development and qualification of biomarkers for Central Nervous System including but not limited to neuron-psychiatry is out as a chapter (https://lnkd.in/dBghcGEP8).
CHCF's response to the NIMH request for feedback about gaps in research and priorities submitted to the agency on May 4th, 2023 (https://1drv.ms/w/s!AlBYqvW-vRmOryn3eOMejfNs9g76?e=rF1VhC).
CHCF's response to the NIMH request for feedback about gaps in research and priorities submitted to the agency on May 4th, 2023 (https://1drv.ms/w/s!AlBYqvW-vRmOryn3eOMejfNs9g76?e=rF1VhC).
Thanks to National Academies of Sciences Engineering and Medicine (Frances Jensen and John Krystal) for organizing this very timely conference which was co chaired by Dr. Linda Brady from NIMH and Dr. Vikas Sharma from Boehringer Ingelheim. The conference focus was on the development and qualification of biomarkers for Central Nervous System including but not limited to neuron-psychiatry (https://www.linkedin.com/posts/cory-heidaran-charitable-foundation_multimodal-biomarkers-for-central-nervous-activity-7043705314335977472-TbhB?utm_source=share&utm_medium=member_ios).
Thanks to National Academies of Sciences Engineering and Medicine (Frances Jensen and John Krystal) for organizing this very timely conference which was co chaired by Dr. Linda Brady from NIMH and Dr. Vikas Sharma from Boehringer Ingelheim. The conference focus was on the development and qualification of biomarkers for Central Nervous System including but not limited to neuron-psychiatry (https://www.linkedin.com/posts/cory-heidaran-charitable-foundation_multimodal-biomarkers-for-central-nervous-activity-7043705314335977472-TbhB?utm_source=share&utm_medium=member_ios).
CHCF will participate in the upcoming conference entitled "Multimodal Biomarkers for Central Nervous System Disorders: Development, Integration, and Clinical Utility - A Workshop"https://www.nationalacademies.org/our-work/multimodal-biomarkers-for-central-nervous-system-disorders-development-integration-and-clinical-utility-a-workshop.
CHCF will participate in the upcoming conference entitled "Multimodal Biomarkers for Central Nervous System Disorders: Development, Integration, and Clinical Utility - A Workshop"https://www.nationalacademies.org/our-work/multimodal-biomarkers-for-central-nervous-system-disorders-development-integration-and-clinical-utility-a-workshop.
Remarkable review paper summarizing how we should approach diagnosis and treatment of serious mental health diseases in an entirely new way. Our current approach is clearly not working (https://www.sciencedirect.com/science/article/pii/S0166223622002582).
Remarkable review paper summarizing how we should approach diagnosis and treatment of serious mental health diseases in an entirely new way. Our current approach is clearly not working (https://www.sciencedirect.com/science/article/pii/S0166223622002582).
We are pleased to announce that CHCF has received the platinum status by GuideStar:
We are pleased to announce that CHCF has received the platinum status by GuideStar:
Recent Published Data Highlighting Epigenetic Control Mechanism
Recent Published Data Highlighting Epigenetic Control Mechanism
SKA2 Methylation is associated with Decreased Prefrontal Cortical Thickness and Greater PTSD Severity among Trauma Exposed Veterans. Naomi Sadeh et al.,
SKA2 Methylation is associated with Decreased Prefrontal Cortical Thickness and Greater PTSD Severity among Trauma Exposed Veterans. Naomi Sadeh et al.,
Can epigenetics shine a light on the biological pathways underlying major mental disorders? Luis Alameda , Giulia Trotta, Harriet Quigley, Victoria Rodriguez, Romayne Gadelrab, Daniella Dwir, Emma Dempster, Chloe C. Y. Wong, and Marta Di Forti
Can epigenetics shine a light on the biological pathways underlying major mental disorders? Luis Alameda , Giulia Trotta, Harriet Quigley, Victoria Rodriguez, Romayne Gadelrab, Daniella Dwir, Emma Dempster, Chloe C. Y. Wong, and Marta Di Forti
An epigenome-wide association study of posttraumatic stress disorder in US veterans implicates several new DNA methylation loci. Mark W. Logue et al.,
An epigenome-wide association study of posttraumatic stress disorder in US veterans implicates several new DNA methylation loci. Mark W. Logue et al.,